Dr. Ashutosh Sharma is a
visiting research assistant professor at the Department
of Chemistry, University of Illinois, Chicago. He completed his PhD studies in Chemistry from Central Drug Research Institute (CDRI) Luckow, India. One of his projects concerns
the design and development of novel ratiometric fluorescent sensors and their
application to quantitative imaging of diverse cellular signaling molecules. He
describes an overview of the design principles for ratiometric fluorescent
sensors and their application to simultaneous in situ quantitative imaging of
two membrane lipids. He has published more than 15 papers in various journals
and serves as an editorial member for Journal of Imaging, Journal of
Chemistry, and ARKIVOC. His research interests inscribe
the design and development of novel molecular fluorescent probes for imaging
and analysis of cellular systems for targeting dysregulation in the signaling
(downstream/upstream) pathways. Currently ongoing research work is based on
the development of the novel drug candidate for the inhibition of membrane
lipid-protein interaction. This inhibition of membrane lipid-protein leads to
the development of novel drug candidate with exceptional efficacy with no
off-target effect and no drug resistance.
Dr. Ashutosh Sharma is a
visiting research assistant professor at the Department
of Chemistry, University of Illinois, Chicago. He completed his PhD studies in Chemistry from Central Drug Research Institute (CDRI) Luckow, India. One of his projects concerns
the design and development of novel ratiometric fluorescent sensors and their
application to quantitative imaging of diverse cellular signaling molecules. He
describes an overview of the design principles for ratiometric fluorescent
sensors and their application to simultaneous in situ quantitative imaging of
two membrane lipids. He has published more than 15 papers in various journals
and serves as an editorial member for Journal of Imaging, Journal of
Chemistry, and ARKIVOC. His research interests inscribe
the design and development of novel molecular fluorescent probes for imaging
and analysis of cellular systems for targeting dysregulation in the signaling
(downstream/upstream) pathways. Currently ongoing research work is based on
the development of the novel drug candidate for the inhibition of membrane
lipid-protein interaction. This inhibition of membrane lipid-protein leads to
the development of novel drug candidate with exceptional efficacy with no
off-target effect and no drug resistance.